In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – For patients with non-ST-segment elevation acute coronary syndrome (nSTE-ACS), long-term outcomes are no different whether they undergo angiography, and revascularization if indicated, within…
NEW YORK (Reuters Health) – Antibiotic prophylaxis based on rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsies (TRUSP) reduces the incidence of post-procedure infectious complications. Furthermore,…
NEW YORK (Reuters Health) – Adding trimetazidine to the treatment of chronic heart failure improves cardiac function and slows left ventricular remodeling, according to the results of a…
NEW YORK (Reuters Health) – In cases of upper gastrointestinal bleeding, intravenous infusion of erythromycin about 30 minutes before endoscopy should be considered to improve diagnostic yield and…
NEW YORK (Reuters Health) – Anakinra is highly effective in treating patients with neonatal-onset multisystem inflammatory disease (NOMID), researchers from the National Institutes of Health report in the…
NEW YORK (Reuters Health) – Lung cancer patients undergoing chemotherapy can be treated safely with erythropoiesis-stimulating agents (ESAs), according to findings published in the 24 January online issue…
NEW YORK (Reuters Health) – Avanafil, another phosphodiesterase type 5 (PDE5) inhibitor, improves sexual function in men with erectile dysfunction, according to a report in the January 16th…
NEW YORK (Reuters Health) – A review suggests that wound-edge protection devices (WEPDs) may be useful in surgical patients, UK researchers report in a January 26th on-line paper…
NEW YORK (Reuters Health) – Birth defects are uncommon in offspring of women exposed to leflunomide before conception or in the first trimester of pregnancy, according to a…
NEW YORK (Reuters Health) – Men 60 years old and younger have excellent quality-of-life outcomes after proton therapy for prostate cancer, according to findings published in the January…
